Justine R Seivright1, Erin Collier1, Tristan Grogan2, Terri Shih1, Marcia Hogeling3, Vivian Y Shi4, Jennifer L Hsiao3. 1. David Geffen School of Medicine, University of California, Los Angeles, California, USA. 2. Department of Medicine Statistics Core, David Geffen School of Medicine, University of California, Los Angeles, California, USA. 3. Division of Dermatology, Department of Medicine, University of California Los Angeles, Los Angeles, California, USA. 4. Department of Dermatology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
Abstract
Introduction: Pediatric hidradenitis suppurativa (HS) is an understudied condition, and the literature describing the provider landscape for this disease is limited. We aim to characterize healthcare utilization in a cohort of pediatric HS patients at an academic institution. Methods: Patients diagnosed with HS before age 18 were identified via retrospective chart review using ICD-9/10 codes for HS. Data on demographics and HS providers were collected. Results: We found that half of the pediatric HS patients first presented to primary care with their HS symptoms. There was a mean delay in diagnosis of 2 years. Dermatologists and pediatricians were the principal HS care providers, and dermatologists most frequently prescribed treatment or procedures (63%). We also found a low rate of utilization of the HS specialty clinic (11%). Females, patients with more severe disease, and patients with earlier age of onset were more likely to be seen by a dermatologist. Conclusions: Dermatologists play a pivotal role in pediatric HS management as principal care providers for patients. Increasing HS awareness among primary care providers, including pediatricians, is critical for early diagnosis and initiation of treatment.
Introduction: Pediatric hidradenitis suppurativa (HS) is an understudied condition, and the literature describing the provider landscape for this disease is limited. We aim to characterize healthcare utilization in a cohort of pediatric HS patients at an academic institution. Methods: Patients diagnosed with HS before age 18 were identified via retrospective chart review using ICD-9/10 codes for HS. Data on demographics and HS providers were collected. Results: We found that half of the pediatric HS patients first presented to primary care with their HS symptoms. There was a mean delay in diagnosis of 2 years. Dermatologists and pediatricians were the principal HS care providers, and dermatologists most frequently prescribed treatment or procedures (63%). We also found a low rate of utilization of the HS specialty clinic (11%). Females, patients with more severe disease, and patients with earlier age of onset were more likely to be seen by a dermatologist. Conclusions: Dermatologists play a pivotal role in pediatric HS management as principal care providers for patients. Increasing HS awareness among primary care providers, including pediatricians, is critical for early diagnosis and initiation of treatment.
Authors: Amit Garg; Erica Neuren; Denny Cha; Joslyn S Kirby; John R Ingram; Gregor B E Jemec; Solveig Esmann; Linnea Thorlacius; Bente Villumsen; Véronique Del Marmol; Aude Nassif; Maia Delage; Thrasyvoulos Tzellos; Dagfinn Moseng; Øystein Grimstad; Haley Naik; Robert Micheletti; Sandra Guilbault; Angie Parks Miller; Iltefat Hamzavi; Hessel van der Zee; Errol Prens; Naomi Kappe; Christine Ardon; Brian Kirby; Rosalind Hughes; Christos C Zouboulis; Georgios Nikolakis; Falk G Bechara; Lukasz Matusiak; Jacek Szepietowski; Amelia Glowaczewska; Saxon D Smith; Noah Goldfarb; Steven Daveluy; Christina Avgoustou; Evangelos Giamarellos-Bourboulis; Steven Cohen; Yssra Soliman; Elena Gonzalez Brant; Oleg Akilov; Christopher Sayed; Jerry Tan; Afsaneh Alavi; Michelle A Lowes; José Carlos Pascual; Hassan Riad; Shani Fisher; Arnon Cohen; So Yeon Paek; Barry Resnik; Qiang Ju; Lanqi Wang; Andrew Strunk Journal: J Am Acad Dermatol Date: 2019-07-03 Impact factor: 11.527
Authors: Carmen Liy-Wong; Mary Kim; A Yasmine Kirkorian; Lawrence F Eichenfield; Lucia Z Diaz; Amir Horev; Megha Tollefson; Teresa Oranges; Roderic Philips; Yvonne E Chiu; Ghazal Ghafari; Justin D Arnold; Jessica Sprague; Henry Nguyen; Stephanie Wan; Eshetu G Atenafu; Elena Pope; Jill Hamilton; Haley B Naik; Irene Lara-Corrales Journal: JAMA Dermatol Date: 2021-04-01 Impact factor: 10.282